Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Calculate exactly how many units of CagriSema to draw on your syringe. Pre-filled with standard defaults.
Draw on your syringe
96
units
(0.960 mL)
96.0% of syringe capacity
Concentration
2,500
mcg/mL
Dose volume
0.960
mL
Doses per vial
2
doses
Cost per dose
---
enter price
Total mcg in vial = 5 mg x 1000 = 5,000 mcg
Concentration = 5,000 mcg / 2 mL = 2,500 mcg/mL
Dose volume = 2400 mcg / 2,500 mcg/mL = 0.9600 mL
Units to draw = 0.9600 mL x 100 units/mL = 96 units
Doses per vial = 5,000 mcg / 2400 mcg = 2.08 doses
Want the full Disclosed Trust Index?
Create a free account to unlock vendor trust scores, the COA scanner, the Forgery Map, and lot lookup across the corpus.
Create a free accountCagriSema is Novo Nordisk's investigational once-weekly fixed-dose co-formulation of cagrilintide 2.4 mg (long-acting amylin analog) with semaglutide 2.4 mg (GLP-1 receptor agonist) for chronic weight management. Unlike the other grey-market blends, it has a proper Phase 3 clinical program. Novo Nordisk filed an FDA NDA in December 2025; as of April 2026 it is under FDA review and not yet approved.
Common vial size
5
mg
Typical BAC water
2
mL
Dose range
2400–2400
mcg
Default dose
2400
mcg
Store refrigerated (2-8°C). Once reconstituted, use within 28 days.
Disclosed Labs